Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- DXCM
- Price
- 67.39
- Stock movement up
- +1.25 (1.89%)
- Company name
- DexCom Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 26.32B
- Ent value
- 30.08B
- Price/Sales
- 6.66
- Price/Book
- 13.30
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 38.66
- Forward P/E
- 33.27
- PEG
- -
- EPS growth
- -
- 1 year return
- -51.73%
- 3 year return
- -19.28%
- 5 year return
- 0.88%
- 10 year return
- 15.61%
Last updated: 2025-04-14
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
DXCM does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 38.66 |
| Price to OCF | 32.03 |
| Price to FCF | 49.20 |
| Price to EBITDA | 26.99 |
| EV to EBITDA | 30.84 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 6.66 |
| Price to Book | 13.30 |
| EV to Sales | 7.61 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 390.60M |
| EPS (TTM) | 1.66 |
| FCF per share (TTM) | 1.30 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 3.95B |
| Gross profit (TTM) | 2.44B |
| Operating income (TTM) | 628.00M |
| Net income (TTM) | 680.80M |
| EPS (TTM) | 1.66 |
| EPS (1y forward) | 2.03 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 61.68% |
| Operating margin (TTM) | 15.88% |
| Profit margin (TTM) | 17.22% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 621.20M |
| Net receivables | 1.03B |
| Total current assets | 4.26B |
| Goodwill | 23.80M |
| Intangible assets | 106.20M |
| Property, plant and equipment | 2.02B |
| Total assets | 6.35B |
| Accounts payable | 326.60M |
| Short/Current long term debt | 2.59B |
| Total current liabilities | 1.73B |
| Total liabilities | 4.37B |
| Shareholder's equity | 1.98B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 821.70M |
| Capital expenditures (TTM) | 286.70M |
| Free cash flow (TTM) | 535.00M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 34.40% |
| Return on Assets | 10.71% |
| Return on Invested Capital | 15.25% |
| Cash Return on Invested Capital | 11.99% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 67.33 |
| Daily high | 68.07 |
| Daily low | 66.41 |
| Daily Volume | 3.64M |
| All-time high | 162.81 |
| 1y analyst estimate | 96.10 |
| Beta | 1.17 |
| EPS (TTM) | 1.66 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 23 Apr 2025 |
Downside potential
Loading...
Downside potential data
| DXCM | S&P500 | |
| Current price drop from All-time high | -58.61% | -12.04% |
| Highest price drop | -94.61% | -56.47% |
| Date of highest drop | 20 Nov 2008 | 9 Mar 2009 |
| Avg drop from high | -34.84% | -11.07% |
| Avg time to new high | 23 days | 12 days |
| Max time to new high | 1828 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
26.32B
Marketcap category
Large-cap
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Employees
9500
Website
Investor relations
-
SEC filings
CEO
Kevin Ronald Sayer
Country
USA
City
San Diego
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page